======= CLCF1 ======= == Gene Information == * **Official Symbol**: CLCF1 * **Official Name**: cardiotrophin like cytokine factor 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23529|23529]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UBD9|Q9UBD9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CLCF1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CLCF1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607672|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene is a member of the glycoprotein (gp)130 cytokine family and encodes cardiotrophin-like cytokine factor 1 (CLCF1). CLCF1 forms a heterodimer complex with cytokine receptor-like factor 1 (CRLF1). This dimer competes with ciliary neurotrophic factor (CNTF) for binding to the ciliary neurotrophic factor receptor (CNTFR) complex, and activates the Jak-STAT signaling cascade. CLCF1 can be actively secreted from cells by forming a complex with soluble type I CRLF1 or soluble CNTFR. CLCF1 is a potent neurotrophic factor, B-cell stimulatory agent and neuroendocrine modulator of pituitary corticotroph function. Defects in CLCF1 cause cold-induced sweating syndrome 2 (CISS2). This syndrome is characterized by a profuse sweating after exposure to cold as well as congenital physical abnormalities of the head and spine. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Oct 2009]. * **UniProt Summary**: Cytokine with B-cell stimulating capability. Binds to and activates the ILST/gp130 receptor. {ECO:0000269|PubMed:10448081, ECO:0000269|PubMed:10500198}. |PRF| |CRLF-CLCF1 complex| |CNTFR-CLCF1 complex| |positive regulation of isotype switching to IgE isotypes| |ciliary neurotrophic factor receptor binding| |regulation of isotype switching to IgE isotypes| |positive regulation of astrocyte differentiation| |positive regulation of isotype switching| |regulation of astrocyte differentiation| |regulation of isotype switching| |positive regulation of immunoglobulin mediated immune response| |positive regulation of B cell mediated immunity| |receptor signaling pathway via JAK-STAT| |positive regulation of DNA recombination| |receptor signaling pathway via STAT| |positive regulation of B cell proliferation| |positive regulation of glial cell differentiation| |positive regulation of immunoglobulin production| |regulation of B cell mediated immunity| |regulation of immunoglobulin mediated immune response| |regulation of B cell proliferation| |regulation of immunoglobulin production| |positive regulation of tyrosine phosphorylation of STAT protein| |regulation of glial cell differentiation| |positive regulation of gliogenesis| |regulation of tyrosine phosphorylation of STAT protein| |positive regulation of receptor signaling pathway via JAK-STAT| |positive regulation of receptor signaling pathway via STAT| |positive regulation of production of molecular mediator of immune response| |positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains| |regulation of DNA recombination| |positive regulation of lymphocyte mediated immunity| |positive regulation of adaptive immune response| |B cell differentiation| |regulation of gliogenesis| |regulation of receptor signaling pathway via JAK-STAT| |positive regulation of lymphocyte proliferation| |positive regulation of mononuclear cell proliferation| |positive regulation of leukocyte mediated immunity| |regulation of receptor signaling pathway via STAT| |positive regulation of leukocyte proliferation| |regulation of production of molecular mediator of immune response| |regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains| |negative regulation of neuron apoptotic process| |regulation of lymphocyte mediated immunity| |B cell activation| |regulation of adaptive immune response| |growth factor activity| |positive regulation of B cell activation| |cytokine activity| |positive regulation of peptidyl-tyrosine phosphorylation| |positive regulation of DNA metabolic process| |regulation of leukocyte mediated immunity| |regulation of neuron apoptotic process| |negative regulation of neuron death| |regulation of B cell activation| |regulation of lymphocyte proliferation| |regulation of mononuclear cell proliferation| |positive regulation of immune effector process| |regulation of leukocyte proliferation| |lymphocyte differentiation| |regulation of peptidyl-tyrosine phosphorylation| |regulation of neuron death| |leukocyte differentiation| |signaling receptor binding| |regulation of DNA metabolic process| |positive regulation of lymphocyte activation| |lymphocyte activation| |positive regulation of leukocyte activation| |positive regulation of cell activation| |regulation of immune effector process| |positive regulation of neurogenesis| |protein heterodimerization activity| |regulation of lymphocyte activation| |positive regulation of nervous system development| |positive regulation of cell development| |hemopoiesis| |regulation of leukocyte activation| |hematopoietic or lymphoid organ development| |regulation of cell activation| |immune system development| |cytokine-mediated signaling pathway| |regulation of neurogenesis| |positive regulation of immune response| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |positive regulation of cell population proliferation| |regulation of nervous system development| |leukocyte activation| |regulation of cell development| |positive regulation of cell differentiation| |negative regulation of cell death| |cellular response to cytokine stimulus| |positive regulation of protein phosphorylation| |positive regulation of phosphorylation| |cell activation| |response to cytokine| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |positive regulation of immune system process| |regulation of immune response| |positive regulation of protein modification process| |positive regulation of developmental process| |regulation of protein phosphorylation| |generation of neurons| |regulation of apoptotic process| |regulation of programmed cell death| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |neurogenesis| |regulation of immune system process| |positive regulation of signal transduction| |regulation of cell death| |positive regulation of protein metabolic process| |positive regulation of multicellular organismal process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| |extracellular region| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp393|Resminostat 0.5μM R07 exp393]]|1.78| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4305 * **Expression level (log2 read counts)**: -2.9 {{:chemogenomics:nalm6 dist.png?nolink |}}